Luciana Vidal Armaganijan

Luciana Vidal Armaganijan

Auto-generated profile, based on publicly available information

Luciana Vidal Armaganijan

Instituto Dante Pazzanese de Cardiologia, Brasil

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 June 2023 in Arquivos Brasileiros de Cardiologia
Verified
Journal Article
Open access
PDF file
JNJose Antonio Marin Neto
Jose Antonio Marin Neto
ARAnis Rassi
Anis Rassi
GOGlaucia Oliveira
Glaucia Oliveira
LCLuís Claudio Lemos Correia
Luís Claudio Lemos Correia
Alberto Novaes Ramos Jr.Alberto Novaes Ramos Jr.
Alberto Novaes Ramos Jr.
JDJoão Carlos Pinto Dias
João Carlos Pinto Dias
Lista de Siglas/Abreviaturas 18 F-FDG – fluordesoxiglicose marcado com flúor-18 123 I-MIBG – meta-iodo-benzil-guanidina marcado com iodo-123 […] Diretriz da SBC sobre Diagnóstico e Tratamento de Pacientes com Cardiomiopatia da Doença de Chagas – 2023 Lista de Siglas/Abreviaturas 18 F-FDG – fluordesoxiglicose marcado com flúor-18 123 I-MIBG – meta-iodo-benzil-guanidina marcado com iodo-123 […] Diretriz da SBC sobre Diagnóstico e Tratamento de Pacientes com Cardiomiopatia da Doença de Chagas – 2023

27 April 2013 in Cardiovascular Psychiatry and Neurology
Verified
Journal Article
Open access
PDF file
DPDimpi Patel
Dimpi Patel
NCNathaniel D. Mc Conkey
Nathaniel D. Mc Conkey
RSRyann Sohaney
Ryann Sohaney
ANAshley Mc Neil
Ashley Mc Neil
AJAndy Jedrzejczyk
Andy Jedrzejczyk
LALuciana Armaganijan
Luciana Armaganijan
Atrial fibrillation (AF) is the most commonly seen arrhythmia in clinical practice. At present, few studies have been conducted centering on depression and anxiety in AF patients. Our aim in this systematic review is to use the relevant literature to (1) describe the prevalence of depression and anxiety in AF patients, (2) assess the impact that depression and anxiety have on illness perception in patients with AF, (3) provide evidence to support a hypothetical connection between the pathophysiology of AF and depression and anxiety, (4) evaluate the benefit of treatment of AF on depression and anxiety, and (5) give insight on medically managing a patient with AF and concomitant depression and anxiety.

16 March 2021 in Journal of Cardiovascular Electrophysiology
Verified
Journal Article
Closed access
PDF file
GPGabriela M. Prado
Gabriela M. Prado
FMFelix Mahfoud
Felix Mahfoud
RLRenato D. Lopes
Renato D. Lopes
DMDalmo Antonio R Moreira
Dalmo Antonio R Moreira
RSRodolfo Staico
Rodolfo Staico
LALuciana V. Armaganijan
Luciana V. Armaganijan

1 January 2022 in Revista da Associação Médica Brasileira
Verified
Journal Article
Open access
GCGuilherme Dagostin de Carvalho
Guilherme Dagostin de Carvalho
LALuciana Vidal Armaganijan
Luciana Vidal Armaganijan
RLRenato Delascio Lopes
Renato Delascio Lopes
MOMárcia Olandoski
Márcia Olandoski
BGBeatriz Millions Do Amaral Galvão
Beatriz Millions Do Amaral Galvão
DMDalmo Antônio Ribeiro Moreira
Dalmo Antônio Ribeiro Moreira
OBJECTIVE: Risk stratification of sudden cardiac death in patients with coronary artery disease is of great importance. We evaluated the association between ventricular repolarization and induction of malignant ventricular arrhythmias on electrophysiological study of patients with coronary artery disease. METHODS AND RESULTS: A total of 177 patients (65 +/- 10.1 years, 83.6% male, mean left ventricular ejection fraction [LVEF] 37.5 +/- 13.6%) were analyzed. For each 10 ms increment in the QT interval, there was a 7% increase in malignant ventricular arrhythmias inducibility; QT cutoff point of 452 ms had an accuracy of 0.611 for predicting malignant ventricular arrhythmias (p=0.011). Male gender (odds ratio [OR]=4.18, p=0.012), LVEF 35% (OR=2.32, p=0.013), amiodarone use (OR=2.01, p=0.038), and prolonged QT (OR=1.07, p=0.023) were associated with malignant ventricular arrhythmias. In patients with ventricular dysfunction, QT 452 ms was associated with significantly increased risk of malignant ventricular arrhythmias (OR=5.44, p=0.0004). In those with LVEF 335%, QT dispersion (QTd) was significantly higher in patients with inducible malignant ventricular arrhythmias. QTd >20 ms had 0.638 accuracy and 81.3% negative predictive value in predicting malignant ventricular arrhythmias. CONCLUSION: QT interval is an independent factor associated with malignant ventricular arrhythmias in patients with coronary artery disease. The combination of ventricular dysfunction and prolonged QT interval is associated with a 5.44-fold increase of malignant ventricular arrhythmias induction. Male gender, amiodarone use, and decreased left ventricular ejection fraction are also associated with increased risk of inducibility of malignant ventricular arrhythmias on the electrophysiological study.

16 September 2025 in Arquivos Brasileiros de Cardiologia
Verified
Journal Article
Closed access
FCFatima Dumas Cintra
Fatima Dumas Cintra
CPCristiano Pisani
Cristiano Pisani
ARAndré Gustavo da Silva Rezende
André Gustavo da Silva Rezende
BHBenhur Davi Henz
Benhur Davi Henz
LALuciana Vidal Armaganijan
Luciana Vidal Armaganijan
VAVeridiana Silva de Andrade
Veridiana Silva de Andrade

14 October 2025 in Arquivos Brasileiros de Cardiologia
Verified
Journal Article
Open access
FCFatima Dumas Cintra
Fatima Dumas Cintra
CPCristiano Pisani
Cristiano Pisani
ARAndré Gustavo da Silva Rezende
André Gustavo da Silva Rezende
BHBenhur Davi Henz
Benhur Davi Henz
LALuciana Vidal Armaganijan
Luciana Vidal Armaganijan
VAVeridiana Silva de Andrade
Veridiana Silva de Andrade